Chinook Therapeutics Inc
KDNY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.71B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.71 Billion |
|---|---|
| Enterprise Value | $2.64 Billion |
| Earnings per Share | $-2.87 |
| Beta | 0.67 |
| Outstanding Shares | 71,592,000 |
Return
| Return on Equity | -68.12% |
|---|---|
| Return on Assets | -49.76% |
| Return on Invested Capital | -57.48% |
Valuation & Multiples
| P/E Ratio | -14.07 |
|---|---|
| PEG | -18.09 |
| Price to Sales | - |
| Price to Book Ratio | 10.1 |
| Enterprise Value to Revenue | 452.09 |
| Enterprise Value to EBIT | -10.54 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Chinook Therapeutics Inc
CEO: Stephen Isaacs
